Advertisement

Picture Eurasanté BioFIT 2017 Strasbourg France November 600x60px
Document › Details

Medigene AG. (11/4/16). "Press Release: Medigene Participates at Six National and International Conferences". Martinsried.

Region Region Germany
Organisations Organisation Medigene AG (MDG1, Frankfurt, Prime Standard)
  Group Medigene (Group)
  Organisation 2 European Organization for Research and Treatment of Cancer (EORTC AISBL / IVWZ)
Products Product BIO-Europe 2016 Köln (Cologne)
  Product 2 TCR engineering technology (T-cell receptor engineering technology)
Person Person Schendel, Dolores J. (Medigene 201602– CEO before CMO before Trianta Immunotherapies + HelmholtzZentrum München)
     


Medigene AG (MDG1, Frankfurt, Prime Standard) announces its participation at six upcoming scientific, investor and business development conferences:


BioEurope

Date: 7 - 9 November 2016
Location: Cologne, Germany


SITC 2016 - Society for Immunotherapy of Cancer

Date: 9 - 13 November 2016
Location: National Harbor, Maryland, USA


Neoantigens Summit

Date: 15 - 17 November 2016
Location: Boston, USA
Prof. Dr. Dolores Schendel, Medigene's CEO/CSO, will give a talk on the topic: "Are we Limited to Treatment of Tumors with High-Mutational Loads and Patients with Pre-Existing Neoantigen-Specific T Cells?"


6th Munich Biomarker Conference

Date: 29 - 30 November 2016
Location: Munich, Germany
Prof. Dr. Dolores Schendel, Medigene's CEO/CSO, will give a keynote talk on the topic: "From personalized to individualized medicine, the next major step in developing the medicine of the future".


EORTC-NCI-AACR Molecular Targets and Cancer Therapeutics Symposium

Date: 29 November - 2 December 2016
Location: Munich, Germany


ASH 2016 - The 58th American Society of Hematology Annual Meeting

Date: 3 - 6 December 2016
Location: San Diego, USA


Medigene AG is a publicly listed (Frankfurt: MDG1, prime standard) biotechnology company headquartered in Martinsried near Munich, Germany. The company is developing highly innovative, complementary treatment platforms to target various types and stages of cancer with candidates in clinical and pre-clinical development. Medigene concentrates on the development of personalized T cell-based immunotherapies.

For more information, please visit www.medigene.com


This press release contains forward-looking statements representing the opinion of Medigene as of the date of this release. The actual results achieved by Medigene may differ significantly from the forward-looking statements made herein. Medigene is not bound to update any of these forward-looking statements. Medigene® is a registered trademark of Medigene AG. This trademark may be owned or licensed in select locations only.


Contact Medigene AG
Julia Hofmann, Dr. Robert Mayer
Tel.: +49 - 89 - 20 00 33 - 33 01,
email: investor@medigene.com

In case you no longer wish to receive any information about Medigene, please inform us by e-mail (investor@medigene.com). We will then delete your address from our distribution list.

   
Record changed: 2017-07-02

Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px

More documents for Medigene (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture Eurasanté BioFIT 2017 Strasbourg France November 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Eurasanté BioFIT 2017 Strasbourg France November 120x80px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px